Caffeic Acid Phenethyl Ester: Its Protective Role Against Certain Major Eye Diseases
| dc.contributor.author | Akyol, Sumeyya | |
| dc.contributor.author | Ugurcu, Veli | |
| dc.contributor.author | Balci, Mehmet | |
| dc.contributor.author | Gurel, Ayse | |
| dc.contributor.author | Erden, Gonul | |
| dc.contributor.author | Cakmak, Ozlem | |
| dc.contributor.author | Akyol, Omer | |
| dc.date.accessioned | 2025-10-24T18:09:16Z | |
| dc.date.available | 2025-10-24T18:09:16Z | |
| dc.date.issued | 2014 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | As an effective compound found mainly in the honeybee product propolis, caffeic acid phenethyl ester (CAPE) has been commonly utilized as a medicine and remedial agent, in a number of countries. Specifically, it might inhibit nuclear factor kappa B at micromolar concentrations and demonstrate antioxidant, antineoplastic, antiproliferative, cytostatic, antiviral, antibacterial, antifungal, and anti-inflammatory features. This review article summarizes the recent progress regarding the favorable effects of CAPE on a number of eye disease models, including cataract and posterior capsule opacification, corneal diseases, retina and optic nerve-related diseases, ischemia/reperfusion injury of retina, inflammation and infection-related diseases. CAPE has been found to exhibit promising efficacy, with minimal adverse effects, in animal and cell culture studies of several eye diseases. | |
| dc.identifier.doi | 10.1089/jop.2014.0046 | |
| dc.identifier.endpage | 708 | |
| dc.identifier.issn | 1080-7683 | |
| dc.identifier.issn | 1557-7732 | |
| dc.identifier.issue | 9 | |
| dc.identifier.pmid | 25100535 | |
| dc.identifier.scopus | 2-s2.0-84932120375 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 700 | |
| dc.identifier.uri | https://doi.org/10.1089/jop.2014.0046 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/3557 | |
| dc.identifier.volume | 30 | |
| dc.identifier.wos | WOS:000344386300004 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Mary Ann Liebert, Inc | |
| dc.relation.ispartof | Journal Of Ocular Pharmacology And Therapeutics | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_20251023 | |
| dc.subject | Staphylococcus-Epidermidis Endophthalmitis; Endotoxin-Induced Uveitis; Endothelial Growth-Factor; Pigment Epithelial-Cells; Induced Diabetic-Rats; Ischemia-Reperfusion; Oxidative Stress; Mouse Skin; Proliferative Vitreoretinopathy; Ischemia/Reperfusion Injury | |
| dc.title | Caffeic Acid Phenethyl Ester: Its Protective Role Against Certain Major Eye Diseases | |
| dc.type | Review Article |












